Targeted &agr;1A-Adrenergic Receptor Overexpression Induces Enhanced Cardiac Contractility but not Hypertrophy

Activation of the &agr;1A-adrenergic receptor (&agr;1A-AR)/Gq pathway has been implicated as a critical trigger for the development of cardiac hypertrophy. However, direct evidence from in vivo studies is still lacking. To address this issue, transgenic mice with cardiac-targeted overexpression of the &agr;1A-AR (4- to 170-fold) were generated, using the rodent &agr;-myosin heavy chain promoter. Heterozygous animals displayed marked enhancement of cardiac contractility, evident from increases in dP/dtmax (80%, P <0.0001), dP/dtmax/LVPinst (76%, P <0.001), dP/dtmax:dP/dtmin (104%, P <0.0001), and fractional shortening (33%, P <0.05). Moreover, changes in the dP/dtmax–end-diastolic volume relationship provided load-independent evidence of a primary increase in contractility. Blood pressure and heart rate were largely unchanged, and there was a small increase in (−)norepinephrine-stimulated, but not basal, phospholipase C activity. Increased contractility was directly related to the level of receptor overexpression and could be completely reversed by acute &agr;1A- but not &bgr;-AR blockade. Despite the robust changes in contractility, transgenic animals displayed no morphological, histological, or echocardiographic evidence of left ventricular hypertrophy. In addition, apart from an increase in atrial natriuretic factor mRNA, expression of other hypertrophy-associated genes was unchanged. To our knowledge, these data provide the first in vivo evidence for an inotropic action of the &agr;1A-AR.

[1]  P. Simpson,et al.  Autonomous and growth factor-induced hypertrophy in cultured neonatal mouse cardiac myocytes. Comparison with rat. , 2000, Circulation research.

[2]  E. Woodcock,et al.  Adverse effects of constitutively active alpha(1B)-adrenergic receptors after pressure overload in mouse hearts. , 2000, American journal of physiology. Heart and circulatory physiology.

[3]  J. Sadoshima,et al.  Myosin light chain kinase mediates sarcomere organization during cardiac hypertrophy in vitro , 2000, Nature Medicine.

[4]  N. Dali-Youcef,et al.  Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Michel,et al.  Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.

[6]  M. Feneley,et al.  Response of the intact canine left ventricle to increased afterload and increased coronary perfusion pressure in the presence of coronary flow autoregulation. , 1999, Circulation.

[7]  J. Lorenz,et al.  Abnormal Cardiac Structure and Function in Mice Expressing Nonphosphorylatable Cardiac Regulatory Myosin Light Chain 2* , 1999, The Journal of Biological Chemistry.

[8]  Dimitrios Georgakopoulos,et al.  The pathogenesis of familial hypertrophic cardiomyopathy: Early and evolving effects from an α-cardiac myosin heavy chain missense mutation , 1999, Nature Medicine.

[9]  E. Woodcock,et al.  Reduced reperfusion-induced Ins(1,4,5)P3 generation and arrhythmias in hearts expressing constitutively active alpha1B-adrenergic receptors. , 1998, Circulation research.

[10]  G. Boivin,et al.  Overexpression of α1B-adrenergic receptor induces left ventricular dysfunction in the absence of hypertrophy. , 1998, American journal of physiology. Heart and circulatory physiology.

[11]  E. Woodcock,et al.  Selective activation of alpha1A-adrenergic receptors in neonatal cardiac myocytes is sufficient to cause hypertrophy and differential regulation of alpha1-adrenergic receptor subtype mRNAs. , 1998, Journal of molecular and cellular cardiology.

[12]  G. Lembo,et al.  Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[13]  M. Cho,et al.  Transgenic Mice with Cardiac Overexpression of α1B-Adrenergic Receptors , 1997, The Journal of Biological Chemistry.

[14]  E. Lakatta,et al.  Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase. , 1997, Circulation research.

[15]  G. Dorn,et al.  Transgenic Gαq overexpression induces cardiac contractile failure in mice , 1997 .

[16]  R. Graham,et al.  α1-Adrenergic Receptor Signaling via Gh Is Subtype Specific and Independent of Its Transglutaminase Activity* , 1996, The Journal of Biological Chemistry.

[17]  P. Sugden,et al.  Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. , 1996, Circulation research.

[18]  R. Graham,et al.  alpha 1-adrenergic receptor subtypes. Molecular structure, function, and signaling. , 1996, Circulation research.

[19]  C. Long,et al.  Alpha1-adrenergic receptor subtype mRNAs are differentially regulated by alpha1-adrenergic and other hypertrophic stimuli in cardiac myocytes in culture and in vivo. Repression of alpha1B and alpha1D but induction of alpha1C. , 1996, The Journal of biological chemistry.

[20]  H. Suga,et al.  Logistic time constant of isovolumic relaxation pressure-time curve in the canine left ventricle. Better alternative to exponential time constant. , 1995, Circulation.

[21]  R. Lefkowitz,et al.  Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[22]  T. Doetschman,et al.  Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. , 1994, Circulation research.

[23]  R. Lefkowitz,et al.  Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. , 1994, Science.

[24]  R. Lefkowitz,et al.  Enhanced Myocardial Function inTransgenic Mice Overexpressing theP2-Adrenergic Receptor , 1994 .

[25]  A. Ardati,et al.  A nuclear pathway for alpha 1‐adrenergic receptor signaling in cardiac cells. , 1993, The EMBO journal.

[26]  K. Chien,et al.  The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. , 1993, The Journal of biological chemistry.

[27]  W. Little,et al.  Comparison of measures of left ventricular contractile performance derived from pressure-volume loops in conscious dogs. , 1989, Circulation.